Bank of Montreal’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,770
Closed -$23.8K 4316
2024
Q1
$23.8K Buy
+2,770
New +$21.3K ﹤0.01% 3594
2022
Q3
Sell
-104
Closed -$2 4470
2022
Q2
$2 Sell
104
-24
-19% -$601 ﹤0.01% 4000
2022
Q1
$5K Buy
128
+27
+27% +$971 ﹤0.01% 4069
2021
Q4
$4K Sell
101
-1
-1% -$53 ﹤0.01% 3432
2021
Q3
$7K Sell
102
-67
-40% -$4.76K ﹤0.01% 3734
2021
Q2
$15K Buy
169
+85
+101% +$8.08K ﹤0.01% 3531
2021
Q1
$9K Buy
+84
New +$9.31K ﹤0.01% 4422
2020
Q4
Hold
0
5148
2020
Q3
Hold
0
4963
2020
Q2
Hold
0
4870
2020
Q1
Hold
0
4804
2019
Q4
Hold
0
5039
2019
Q3
Hold
0
5030
2019
Q2
Hold
0
5099
2019
Q1
Hold
0
4810
2018
Q4
Hold
0
4886
2018
Q3
Hold
0
4924
2018
Q2
Hold
0
4905
2018
Q1
Hold
0
4373
2017
Q4
Hold
0
4354
2017
Q3
Hold
0
4349
2017
Q2
Hold
0
4322
2017
Q1
Hold
0
4222
2016
Q4
Sell
-50
Closed -$18.6K 4217
2016
Q3
$17K Sell
50
-100
-67% -$35K ﹤0.01% 3412
2016
Q2
$49K Hold
150
﹤0.01% 3065
2016
Q1
$50K Buy
150
+100
+200% +$33K ﹤0.01% 3048
2015
Q4
$23K Buy
+50
New +$31.4K ﹤0.01% 3344
2015
Q3
Hold
0
4195
2015
Q2
Hold
0
3860
2015
Q1
Hold
0
3807
2014
Q4
Hold
0
3789
2014
Q3
Hold
0
3770
2014
Q2
Hold
0
4184
2014
Q1
Hold
0
3807
2013
Q4
Hold
0
3515
2013
Q3
Hold
0
3512
2013
Q2
Hold
0
3358

Other funds holding CSCI

Bank of Montreal's CSCI Position: Q2 2024 in Review

Bank of Montreal sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2024, closing a stake of 2,770 shares — an estimated $23.8K sold.

Bank of Montreal first reported a position in CSCI in Q4 2015 and held it in 11 quarters. The position peaked at $50K in Q1 2016. 13 funds tracked by Wall St. Rank hold CSCI as of Q2 2024.

  • Bank of Montreal reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 2,770 COSCIENS Biopharma Inc. Common Stock shares in Q2 2024, an estimated $23.8K.
  • Bank of Montreal first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2015 and held it in 11 quarters.
  • Bank of Montreal's COSCIENS Biopharma Inc. Common Stock position peaked at $50K in Q1 2016.
  • 13 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.